aesthetic clinics role in glp-1 patient care Body Contouring After Weight Loss: Complete Guide to Managing Loose Skin from Semaglutide and Tirzepatide GLP-1 medications like Ozempic are

FDA decision is not expected until mid-2027

This prevents systemic inflammation by ensuring the gut barrier remains an effective filter against toxins

By stimulating insulin release and inhibiting glucagon, helps stabilize blood sugar levels, reducing the risk of hyperglycemia, insulin resistance, and type 2 diabetes

Learning Objectives: List the two types of glucagon-like peptide-1 (GLP-1) medications approved for weight loss Describe the proposed mechanism of action for GLP-1s and glucose-dependent insulinotropic peptide (GIP) medications Explain where GLP receptors are found List three data points on efficacy outcomes of GLP-1s List five main side effects of GLP-1s Explain the relationship between GLP dose and side effects Describe what mindful eating is and how it can be used to help optimize nutritional status and ameliorate the side effects of GLP-1s List three pieces of motivational interviewing (MI) dialogue to help assess the impact of a GLP-1 to inform the counseling focus Using Mindful Eating with GLP-1 Medications webinar presents the benefits of coupling a mindful eating approach with weight loss medication for personalized and effective care

Triple treatment did not blunt olanzapine induced increases in glucagon (Figure 3F), glucagon:insulin (Figure 3G), NEFA (Figure 3H), or glycerol (Figure 3I)